MET and lung cancer: To address these challenges, we have developed a novel dPCR assay at the Molecular Laboratory, Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, that can accurately detect and discriminate between focal and non-focal MET amplification in lung cancer samples.